Breaking News

NexPoint Invests in Trust Fund with Focus on CDMOs, cGMPs Facilities

NexPoint sees a significant demand in the US for facilities that meet the standards of current cGMP.

NexPoint, an investment platform, has made an initial investment in NexPoint Life Sciences II DST, a Delaware statutory trust (DST), through a fund advised by its affiliate. The investment aligns NexPoint’s and DST investors’ interests and underscores the firm’s commitment to the life sciences sector. The DST acquired the two properties earlier this year in Philadelphia that are occupied by a subsidiary of Adare Pharmaceuticals Inc., a contract development and manufacturing or...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters